Abstract:A non-coding region on chromosome 9p21 was previously shown to associate with coronary artery disease and type 2 diabetes, and the region has been implicated in regulating neighbouring genes. Here the authors identify 33 distinct enhancers within this region and show that single nucleotide polymorphisms in one of the enhancers affect STAT1 binding. They further show that in human vascular endothelium cells, the enhancer interval physically interacts with a number of specific loci, and that interferon-γ activation strongly affects the chromatin structure and transcriptional regulation of the 9p21 locus, including STAT1 binding, long-range enhancer interactions and expression of neighbouring genes. A non-coding region on chromosome 9p21 was previously shown to associate with coronary artery disease and type 2 diabetes, and the region has been implicated in regulating neighbouring genes. Here, 33 distinct enhancers within this region are identified, showing that SNPs in one of the enhancers affect STAT1 binding. Furthermore, it is shown that in human vascular endothelial cells the enhancer interval physically interacts with a number of specific loci and that IFN-γ activation strongly affects the chromatin structure and transcriptional regulation of the 9p21 locus, including STAT1 binding, long-range enhancer interactions and expression of neighbouring genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in the 9p21 gene desert associated with coronary artery disease (CAD)1,2,3,4 and type 2 diabetes5,6,7. Despite evidence for a role of the associated interval in neighbouring gene regulation8,9,10, the biological underpinnings of these genetic associations with CAD or type 2 diabetes have not yet been explained. Here we identify 33 enhancers in 9p21; the interval is the second densest gene desert for predicted enhancers and six times denser than the whole genome (P < 6.55 × 10−33). The CAD risk alleles of SNPs rs10811656 and rs10757278 are located in one of these enhancers and disrupt a binding site for STAT1. Lymphoblastoid cell lines homozygous for the CAD risk haplotype show no binding of STAT1, and in lymphoblastoid cell lines homozygous for the CAD non-risk haplotype, binding of STAT1 inhibits CDKN2BAS (also known as CDKN2B-AS1) expression, which is reversed by short interfering RNA knockdown of STAT1. Using a new, open-ended approach to detect long-distance interactions, we find that in human vascular endothelial cells the enhancer interval containing the CAD locus physically interacts with the CDKN2A/B locus, the MTAP gene and an interval downstream of IFNA21. In human vascular endothelial cells, interferon-γ activation strongly affects the structure of the chromatin and the transcriptional regulation in the 9p21 locus, including STAT1-binding, long-range enhancer interactions and altered expression of neighbouring genes. Our findings establish a link between CAD genetic susceptibility and the response to inflammatory signalling in a vascular cell type and thus demonstrate the utility of genome-wide association study findings in directing studies to novel genomic loci and biological processes important for disease aetiology.

Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease

Association Of Snp Rs6903956 On Chromosome 6p24.1 With Angiographical Characteristics Of Coronary Atherosclerosis In A Chinese Population

Polymorphisms on chromosome 9p21 confer a risk for acute coronary syndrome in a Chinese Han population.

Abstract 076: the Blood Pressure-associated Non-coding Single Nucleotide Polymorphism Rs28451064 Influences Gene Expression in Human Endothelial Cells

9P21 DNA Variants Associated with Coronary Artery Disease Impair Interferon-Γ Signalling Response

Micro-capture-C in vessel wall cell types identifies mechanisms underlying coronary artery disease susceptibility loci

Association of Common Polymorphisms in the Lrp6 Gene with Sporadic Coronary Artery Disease in A Chinese Population

Two Tagsnps Rs352493 And Rs3760908 Within Sirt6 Gene Are Associated With The Severity Of Coronary Artery Disease In A Chinese Han Population

Integration of Summary Data from GWAS and Eqtl Studies Identified Novel Risk Genes for Coronary Artery Disease

The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic state

Convergence of coronary artery disease genes onto endothelial cell programs

Genetic Regulation of the Thymic Stromal Lymphopoietin (TSLP)/TSLP Receptor (TSLPR) Gene Expression and Influence of Epistatic Interactions Between IL-33 and the TSLP/TSLPR Axis on Risk of Coronary Artery Disease

Abstract 346: 9p21.3 Coronary Artery Disease Risk Variants Disrupt Tead Transcription Factor Binding and Tead-dependent Tgfβ Induction of P16 Expression

Abstract 151: Single Cell Transcriptional and Epigenetic Map of Human Coronary Artery Disease in A Multi-ethnic Population

Abstract 2072: The 9p21.3 Coronary Artery Disease Risk Locus Induces Cell State Transitions In Vascular Smooth Muscle Cells

Genome-Wide Association and Functional Studies Identify SCML4 and THSD7A As Novel Susceptibility Genes for Coronary Artery Disease.

Comprehensive identification of coronary artery disease-associated variants regulating vascular smooth muscle cell gene expression

Down-regulated RGS5 by Genetic Variants Impairs Endothelial Cell Function and Contributes to Coronary Artery Disease.

Association of PLCL 2 and AP 3 D 1-DOT 1 LSF 3 A 2 variants with the risk of coronary artery disease and its clinical phenotypes in a Chinese population

Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.

Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus